That's an excellent question.
You're right. Drug shortages actually have existed beyond this current round of, specifically, pediatric shortages. That relates to some of those regulatory issues that I talked about.
There are many drugs that are not widely available in Canada, so through our special access program we essentially import and do one-off importation for them as a routine matter. That is something that continues to this day. It has been worsened by the pandemic in terms of common children's medications like Tylenol, Advil and antibiotics. I think it gets back to, in large part, what I was talking about related to regulation.
We struggle with having child-friendly drugs available in Canada, because our regulatory system doesn't push manufacturers or support manufacturers to make those drugs widely available, so there's more we can do on that through incentives and through mandates to be applying for needed drugs.